Immune Checkpoint Inhibitors: Common Questions About Uncommon Adverse Events
Presented by Lisa Kottschade, APRN, MSN, CNP
From Mayo Clinic, Rochester, Minnesota
J Adv Pract Oncol 2021;12(3):289–292 |
© 2021 Harborside™
At JADPRO Live Virtual 2020, Lisa Kottschade, APRN, MSN, CNP, highlighted considerations for advanced practitioners on the recognition and monitoring of rare and life-threatening immune-related adverse events (irAEs), as well as strategies for managing patients who have corticosteroid-refractory irAEs.
For access to the full length article, please sign in